La catena delle opzioni mostra i dati chiave delle opzioni azionarie di Milestone Pharmaceuticals a vari prezzi di esercizio e date di scadenza. I trader utilizzano queste informazioni per analizzare potenziali operazioni e valutare il sentiment del mercato per Milestone Pharmaceuticals..

Milestone Pharmaceuticals (NASDAQ:MIST) Azioni, Catena delle Opzioni

Milestone Pharmaceuticals

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals Inc

Mist

Mister Car Wash Inc

MISTRAS Group Inc

Press Releases

Alpha Cognition Strengthens Its Leadership Team with Appointment of Robert Wills to Board of Directors and Announces Departure of Existing Director John Havens

Earnings

Milestone Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

News

Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference

Health Care

Milestone Pharmaceuticals Submits Response to the FDA's CRL for CARDAMYST (etripamil) Nasal Spray for PSVT Following Type A Meeting

General

Milestone Pharmaceuticals Announces FDA Acceptance of the Company's Response to the CRL for CARDAMYST™ (etripamil) Nasal Spray

IPOs

Milestone Pharmaceuticals Announces Proposed Public Offering

Financing

Milestone Pharmaceuticals Announces Pricing of $52.5 Million Public Offering of Common Shares, Pre-Funded Warrants, Series A Common Warrants and Series B Common Warrants

Milestone Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Regulatory and Corporate Update

Milestone® Pharmaceuticals to Present at Upcoming Conferences

Milestone® Pharmaceuticals to Present Data on Etripamil at the American Heart Association Scientific Sessions 2025

ACOG

CBAY

MIST

ONCT

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

Anebulo Pharmaceuticals, Inc. - Common Stock

Anebulo Pharmaceuticals

Alto Neuroscience

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Bioage Labs

Cognition Therapeutics, Inc. - Common Stock

Cognition Therapeutics

Context Therapeutics

Cybin

Journey Medical Corporation - Common Stock

Journey Medical

High Tide

ImageneBio

MediWound

NeOnc Technologies Holdings, Inc. - Common Stock

NeOnc Technologies Hldgs

Nutriband

Organigram Global

Omeros

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Cassava Sciences

Scilex Holding

Sol-Gel Technologies Ltd. - Ordinary Shares

Sol-Gel Technologies

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Universe Pharmaceuticals Inc - Ordinary Shares

Universe Pharmaceuticals

Ventyx Biosciences

Zhengye Biotechnology Holding Limited - Ordinary Shares

Zhengye Biotechnology

Wells Fargo

HC Wainwright & Co.

Rodman & Renshaw

Piper Sandler

Comments

Milestone Pharmaceuticals

Milestone Pharmaceuticals (MIST) Opzioni

Milestone Pharmaceuticals (NASDAQ:MIST) Azioni, Catena delle Opzioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO